Oxycodon Hcl Retard Lannacher (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon Hcl Retard Lannacher, is an opioid analgesic presented as a controlled‑release oral formulation for systemic use. It is indicated for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodon Hcl Retard Lannacher as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodon Hcl Retard Lannacher as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodon Hcl Retard is an opioid analgesic that acts within the central nervous system to relieve pain.

- Chronic cancer‑related pain: provides sustained relief for patients with persistent tumor‑associated pain. - Post‑operative pain: manages moderate to severe pain following major surgical procedures. - Severe non‑cancer chronic pain: reduces pain intensity in conditions such as severe osteoarthritis or neuropathic pain when other treatments have failed. - Acute severe injury pain: controls intense pain from traumatic injuries requiring strong analgesia. - Palliative care pain: alleviates distressing pain in end‑of‑life care settings.

Oxycodon Hcl Retard may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: feeling of queasiness, often accompanied by vomiting. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivary flow causing oral discomfort. - Dizziness: light‑headed sensation, especially on standing. - Sweating: excessive perspiration unrelated to temperature.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure leading to fainting. - Opioid use disorder: dependence or addiction with compulsive use. - Seizures: rare occurrence of convulsive episodes. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Adrenal insufficiency: impaired cortisol production causing fatigue and weakness.

When prescribing Oxycodon Hcl Retard, clinicians should evaluate patient history and monitor for specific safety concerns.

- Assess renal and hepatic function: adjust therapy if impairment is present. - Evaluate for respiratory disorders: avoid in patients with severe COPD or sleep‑apnea. - Screen for substance‑use disorder: consider risk of dependence before initiating therapy. - Use caution in the elderly: increased sensitivity to sedative effects and falls. - Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Oxycodon Hcl Retard can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can cause profound respiratory depression. - Muscle relaxants: additive sedative effects increase risk of overdose. - MAO inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodone plasma levels, requiring dose adjustment. - CYP3A4 inducers (e.g., rifampicin): reduce oxycodone exposure, potentially decreasing analgesia. - Antihistamines: may enhance drowsiness and dizziness. - Antidepressants (SSRIs/SNRIs): can modestly increase serotonergic activity, monitoring for serotonin syndrome. - Diuretics: may potentiate hypotensive effects, especially orthostatic changes.